000 | 01112 a2200313 4500 | ||
---|---|---|---|
005 | 20250511234722.0 | ||
264 | 0 | _c19900629 | |
008 | 199006s 0 0 hun d | ||
022 | _a0030-6002 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMüzes, G | |
245 | 0 | 0 |
_a[Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)]. _h[electronic resource] |
260 |
_bOrvosi hetilap _cApr 1990 |
||
300 |
_a863-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; English Abstract; Journal Article | ||
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aFlavonoids _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 |
_aLiver Diseases, Alcoholic _xdrug therapy |
650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
650 | 0 | 4 |
_aSilymarin _xpharmacology |
700 | 1 | _aDeák, G | |
700 | 1 | _aLáng, I | |
700 | 1 | _aNékám, K | |
700 | 1 | _aNiederland, V | |
700 | 1 | _aFehér, J | |
773 | 0 |
_tOrvosi hetilap _gvol. 131 _gno. 16 _gp. 863-6 |
|
999 |
_c2351710 _d2351710 |